ClinicalTrials.gov
public full text
Public Domain
Safety and Immunogenicity of a Novel H5N1 Influenza Vaccine in Healthy Adults Age 18-49 Years
This study will evaluate the safety and immunogenicity of VAX161B \[STF2.HA5 H5N1\], a recombinant, inactivated, subunit influenza vaccine given as a two dose regimen at a range of doses.
Conceptio Open Archive
Analyze & explore related research in Conceptio
Connect this record directly into your research workflow or AI agent. Explore citations across open repositories, query full text, and export structured proof bundles.
This document is indexed with metadata only: full text is not available in the archive for this record. Open the official source ↗
Related documents
- Safety and Immunogenicity of VAX125 Influenza Vaccine in Community-living Adults >= 65 Years of Age#993390
- Safety and Immunogenicity of Two Doses of H5N1 Influenza Vaccine in Children#882029
- Phase 1 Safety Study of Recombinant Influenza Vaccine for Prevention#805824
- H5N1 Vaccine Study in Japanese Adults#834783
- Safety Trial of Monovalent Whole Virus Influenza (H1N1) Vaccine#154753
Record · ID 1420609
Retrieved via Conceptio: every document is proof-bundled with source, license, and retrieval metadata.
Retrieved via Conceptio: every document is proof-bundled with source, license, and retrieval metadata.
Bring this data into your agent: Connect via MCP or API · 20 free credits to start · no card required
Read the Docs → · View CLI source on GitHub · Conceptio Open Knowledge Archive
Read the Docs → · View CLI source on GitHub · Conceptio Open Knowledge Archive